Please login to the form below

Not currently logged in
Email:
Password:

Robert Simon to lead regulatory affairs at Threshold

Will oversee approval process for cancer treatment TH-302 in development with Merck KGaA

Robert Simon has joined Threshold Pharmaceuticals as its senior VP of regulatory affairs and will oversee regulatory activities for investigational cancer treatment TH-302, which the company is developing in partnership with Merck KGaA.

Threshold wants to tap into Simon's 28 years of experience in drug development and regulatory affairs as it attempts to launch the drug in several areas of oncology, including soft tissue sarcoma and pancreatic cancer.

“Bob has played key roles in the successful registration of more than a dozen new drug applications worldwide, including the established oncology drugs, Tarceva and Taxol," said Dr Tillman Pearce, chief medical officer of Threshold.

Prior to joining Threshold, Simon spent almost a decade at OSI Pharmaceuticals, in roles that included VP of global regulatory affairs and chemistry manufacturing controls (CMC) for oncology, as well as executive VP.

He has also spent time at Gilead as VP of global regulatory affairs following a 13-year spell at Bristol-Myers Squibb in several regulatory affairs positions.

"I am looking forward to working with the Threshold team in developing the first hypoxia-targeted cancer drug, TH-302," said Simon.

26th April 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page

For those who can imagine better, Page & Page is home to meaningful encounters of a marketing, communication and creative kind:...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics